3 ms·
> highly neutralizing COVID-19 convalescent plasma Basically, you take the blood plasma of someone recently recovered from COVID-19 with high antibody counts a
by mschuster91 5y ago
> highly neutralizing COVID-19 convalescent plasma
Basically, you take the blood plasma of someone recently recovered from COVID-19 with high antibody counts and filter antibodies out of it, that are then administered to critically ill patients. Same procedure is used in manufacturing snake venom antidotes (with horses as host bodies, since they are able to resist snake bites). More about this can be read e.g. here: https://www.mayoclinic.org/tests-procedures/convalescent-plasma-therapy/about/pac-20486440 https://www.mayoclinic.org/tests-procedures/convalescent-pla...
As for the different type of antibody - tl;dr of https://www.ptglab.com/news/blog/polyclonal-vs-monoclonal-antibodies/ https://www.ptglab.com/news/blog/polyclonal-vs-monoclonal-an... is "monoclonal antibodies are all of the same configuration and target one specific molecule, whereas polyclonal antibodies have a higher amount of variance in matching".
As for "what exactly did they do" - they took samples of the specific virus and exposed it to such a blood plasma sample, and noticed escape, aka surviving infectious viruses. Which in turn is bad news as it means that this specific strain of virus at least has the potential capability to evade the body's immune system protection that has been built up by infection or immunization.
As this is an "in vitro" test though, this means that it may also be possible that an "in vivo" test (=exposing a live human instead of a blood sample) would fail.